HEALTHCARE
Global DNA And Gene Cloning Services Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global DNA And Gene Cloning Services Market, By Product Type (Gene Synthesis, Custom Cloning, Sub-cloning, Others), Company Size (Small, Mid-size, Large), Type of Gene (Standard Gene, Complex Gene, Others), Application (DNA Sequencing, Mutagenesis, Genotyping, Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Rising prevalence of genetic disorders and diseases.
- Growing investment in R&D by biotech companies.
- High costs associated with DNA and gene cloning services.
- Ethical concerns and regulatory challenges.
- Expansion into emerging markets.
- Development of novel cloning techniques.
- Stringent regulatory approvals and compliance.
- Ethical and social acceptance issues.
SEGMENTATION
- Product Type
- Gene Synthesis
- Custom Cloning
- Sub-cloning
- Others
- Company Size
- Small
- Mid-size
- Large
- Type of Gene
- Standard Gene
- Complex Gene
- Others
- Application
- DNA Sequencing
- Mutagenesis
- Genotyping
- Others
- End-user
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Bio-Techne
- Charles River Laboratories
- Eurofins Scientific
- GenScript
- Danaher Corporation
- Syngene International Limited
- Twist Bioscience
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Curia Global, Inc.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global DNA And Gene Cloning Services Market, by Product Type
- 3.2 Global DNA And Gene Cloning Services Market, by Company Size
- 3.3 Global DNA And Gene Cloning Services Market, by Type of Gene
- 3.4 Global DNA And Gene Cloning Services Market, by Application
- 3.5 Global DNA And Gene Cloning Services Market, by End-user
- 3.6 Global DNA And Gene Cloning Services Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Growing adoption of CRISPR technology.
- 5.1.2 Advancements in synthetic biology.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising prevalence of genetic disorders and diseases.
- 5.2.2 Growing investment in R&D by biotech companies.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High costs associated with DNA and gene cloning services.
- 5.3.2 Ethical concerns and regulatory challenges.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Expansion into emerging markets.
- 5.4.2 Development of novel cloning techniques.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Stringent regulatory approvals and compliance.
- 5.5.2 Ethical and social acceptance issues.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY PRODUCT TYPE
- 6.1 Product Type Summary
- 6.2 Market Attractive Index
- 6.3 Global DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- SECTION 7 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY COMPANY SIZE
- 7.1 Company Size Summary
- 7.2 Market Attractive Index
- 7.3 Global DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- SECTION 8 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY TYPE OF GENE
- 8.1 Type of Gene Summary
- 8.2 Market Attractive Index
- 8.3 Global DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- SECTION 9 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global DNA And Gene Cloning Services Market, by Application (2019-2032)
- SECTION 10 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY END-USER
- 10.1 End-user Summary
- 10.2 Market Attractive Index
- 10.3 Global DNA And Gene Cloning Services Market, by End-user (2019-2032)
- SECTION 11 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global DNA And Gene Cloning Services Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA DNA AND GENE CLONING SERVICES MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- 12.4 North America DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- 12.5 North America DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- 12.6 North America DNA And Gene Cloning Services Market, by Application (2019-2032)
- 12.7 North America DNA And Gene Cloning Services Market, by End-user (2019-2032)
- 12.8 North America DNA And Gene Cloning Services Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE DNA AND GENE CLONING SERVICES MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- 13.4 Europe DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- 13.5 Europe DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- 13.6 Europe DNA And Gene Cloning Services Market, by Application (2019-2032)
- 13.7 Europe DNA And Gene Cloning Services Market, by End-user (2019-2032)
- 13.8 Europe DNA And Gene Cloning Services Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC DNA AND GENE CLONING SERVICES MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- 14.4 Asia-Pacific DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- 14.5 Asia-Pacific DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- 14.6 Asia-Pacific DNA And Gene Cloning Services Market, by Application (2019-2032)
- 14.7 Asia-Pacific DNA And Gene Cloning Services Market, by End-user (2019-2032)
- 14.8 Asia-Pacific DNA And Gene Cloning Services Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA DNA AND GENE CLONING SERVICES MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- 15.4 South America DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- 15.5 South America DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- 15.6 South America DNA And Gene Cloning Services Market, by Application (2019-2032)
- 15.7 South America DNA And Gene Cloning Services Market, by End-user (2019-2032)
- 15.8 South America DNA And Gene Cloning Services Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA DNA AND GENE CLONING SERVICES MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa DNA And Gene Cloning Services Market, by Product Type (2019-2032)
- 16.4 Middle East and Africa DNA And Gene Cloning Services Market, by Company Size (2019-2032)
- 16.5 Middle East and Africa DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
- 16.6 Middle East and Africa DNA And Gene Cloning Services Market, by Application (2019-2032)
- 16.7 Middle East and Africa DNA And Gene Cloning Services Market, by End-user (2019-2032)
- 16.8 Middle East and Africa DNA And Gene Cloning Services Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global DNA And Gene Cloning Services Market, Company Share Analysis
- 17.2 North America DNA And Gene Cloning Services Market, Company Share Analysis
- 17.3 Europe DNA And Gene Cloning Services Market, Company Share Analysis
- 17.4 Asia-Pacific DNA And Gene Cloning Services Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 Bio-Techne
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Charles River Laboratories
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Eurofins Scientific
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 GenScript
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Danaher Corporation
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Syngene International Limited
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Twist Bioscience
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 Thermo Fisher Scientific Inc.
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Merck KGaA
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Curia Global, Inc.
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.